“China’s strategy is based on a central advantage: access to vast amounts of data, especially in the field of genetics. While Western countries work with high hurdles in data protection and ethical guidelines, China operates within a state-controlled framework that declares the use of sensitive data a priority for economic and security policy. The 2023 updated Human Genetic Resources Regulation allows targeted use of genetic and health-related data – but under state control. These conditions enable faster clinical trials, more efficient drug development and ultimately an accelerated innovation cycle.”
– Renata Thiébaut, Professor of Marketing at the Gisma University of Applied Science and expert in e-commerce, digital marketing and digitization, in “China’s Recipe for Success in Artificial Intelligence” – The success of Deepseek was no accident. Beijing relies on targeted data use and scaling. The advantages lie in the rapid implementation. This accelerates innovations.”, guest commentary in Handelsblatt, May 13, 2025, page 22, No. 91
